Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
13 mg [14C]-A4250 capsule----[3] 93, 297, 338 💬
2[A4250]----[3] 296, 297, 338 💬
3[Maralixibat][1] Maralixibat[2] Maralixibat ,
Maralixibat chloride 💬
[2] SLC10A1,
SLC10A2 💬
[3] Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬[2] 296, 338 💬
4A4250----[4] 93, 296, 297, 338 💬
5A4250 (1200 µg)----[1] 338 💬
6A4250 (200 µg)----[1] 338 💬
7A4250 (400 µg)----[1] 338 💬
8A4250 (600 µg)----[1] 338 💬
9A4250 (odevixibat)[1] Odevixibat[2] Odevixibat ,
Odevixibat hydrate 💬
[1] SLC10A2 💬 [1] Bile secretion 💬[1] 338 💬
10CRC (A3384)----[3] 93, 297, 338 💬
11Livmarli----[2] 297, 338 💬
12Livmarli Oral Product----[2] 297, 338 💬
13LUM001----[4] 93, 94, 297, 338 💬
14LUM001 (Maralixibat)[1] Maralixibat[2] Maralixibat ,
Maralixibat chloride 💬
[2] SLC10A1,
SLC10A2 💬
[3] Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬[2] 297, 338 💬
15Maralixibat[1] Maralixibat[2] Maralixibat ,
Maralixibat chloride 💬
[2] SLC10A1,
SLC10A2 💬
[3] Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬[4] 296, 297, 299, 338 💬
16Maralixibat (formely SHP625 or LUM001)[1] Maralixibat[2] Maralixibat ,
Maralixibat chloride 💬
[2] SLC10A1,
SLC10A2 💬
[3] Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬[3] 296, 297, 338 💬
17Maralixibat (formely SHP625 or LUM001)Pharmaceutical Form: Oral solutionINN or Proposed INN: MARALIXIBAT CHLORIDECAS Number: 228113-66-4Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 5-Product Name: Maralixibat (formely SHP625 or LUM001)Pharmaceutical Form: Oral solutionINN or Proposed INN: MARALIXIBAT CHLORIDECAS Number: 228113-66-4Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 10-Product Name: Maralixibat (formely SHP625 or LUM001)Pharmaceutical Form: Oral solutionINN or Proposed INN: MARALIXIBAT CHLORIDECAS Number: 228113-66-4Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 15-Product Name: Maralixibat (formely SHP625 or LUM001)Pharmaceutical Form: Oral solutionINN or Proposed INN: MARALIXIBAT CHLORIDECAS Number: 228113-66-4Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 20-[1] Maralixibat[2] Maralixibat ,
Maralixibat chloride 💬
[2] SLC10A1,
SLC10A2 💬
[3] Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬[3] 296, 297, 338 💬
18Maralixibat (formerly SHP625 or LUM001)[1] Maralixibat[2] Maralixibat ,
Maralixibat chloride 💬
[2] SLC10A1,
SLC10A2 💬
[3] Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬[1] 338 💬
19Maralixibat (in precedenza SHP625 o LUM001)[1] Maralixibat[2] Maralixibat ,
Maralixibat chloride 💬
[2] SLC10A1,
SLC10A2 💬
[3] Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬[1] 338 💬
20MARALIXIBAT CHLORIDE[1] Maralixibat[2] Maralixibat ,
Maralixibat chloride 💬
[2] SLC10A1,
SLC10A2 💬
[3] Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬[3] 296, 297, 338 💬
21Maralixibat cloruro[1] Maralixibat[2] Maralixibat ,
Maralixibat chloride 💬
[2] SLC10A1,
SLC10A2 💬
[3] Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬[2] 296, 338 💬
22MRX Drug Substance (formerly Maralixibat , SHP625 or LUM001)[1] Maralixibat[2] Maralixibat ,
Maralixibat chloride 💬
[2] SLC10A1,
SLC10A2 💬
[3] Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬[1] 338 💬
23MRX Drug Substance (formerly Maralixibat, SHP625 or LUM001)[1] Maralixibat[2] Maralixibat ,
Maralixibat chloride 💬
[2] SLC10A1,
SLC10A2 💬
[3] Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬[1] 338 💬
24Odevixibat[1] Odevixibat[2] Odevixibat ,
Odevixibat hydrate 💬
[1] SLC10A2 💬 [1] Bile secretion 💬[3] 296, 297, 338 💬
25Questran----[4] 93, 254, 297, 338 💬
26TAK-625----[2] 297, 338 💬